These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6615700)

  • 1. Anti-tumour cytotoxin produced by human monocytes: studies on its mode of action.
    Matthews N
    Br J Cancer; 1983 Sep; 48(3):405-10. PubMed ID: 6615700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumour cytotoxin from macrophages: no correlation between cytotoxin adsorption by tumour cell lines and their cytotoxin susceptibility.
    Matthews N
    Immunology; 1984 Nov; 53(3):537-43. PubMed ID: 6490095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of human monocyte killing of tumour cells of antibody raised against an extracellular monocyte cytotoxin.
    Matthews N
    Immunology; 1983 Feb; 48(2):321-7. PubMed ID: 6337089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of an anti-tumour cytotoxin by human monocytes.
    Matthews N
    Immunology; 1981 Sep; 44(1):135-42. PubMed ID: 7275181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro production of rabbit macrophage tumor cell cytotoxin.
    Fisch H; Gifford GE
    Int J Cancer; 1983 Jul; 32(1):105-12. PubMed ID: 6862689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin.
    Cathcart MK; McNally AK; Morel DW; Chisolm GM
    J Immunol; 1989 Mar; 142(6):1963-9. PubMed ID: 2537865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor.
    Chen AR; McKinnon KP; Koren HS
    J Immunol; 1985 Dec; 135(6):3978-87. PubMed ID: 3905966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell lines.
    Creasey AA; Doyle LV; Reynolds MT; Jung T; Lin LS; Vitt CR
    Cancer Res; 1987 Jan; 47(1):145-9. PubMed ID: 3791201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
    Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
    J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytostatic and cytotoxic activity of tumor necrosis factor on human cancer cells.
    Ruggiero V; Latham K; Baglioni C
    J Immunol; 1987 Apr; 138(8):2711-7. PubMed ID: 3031163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte-mediated drug-dependent cellular cytotoxicity: effects on different WEHI 164 target cell lines.
    Austgulen R; Kildahl-Andersen O; Espevik T
    Cancer Immunol Immunother; 1986; 22(3):176-80. PubMed ID: 3731202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monocyte-released cytotoxic factor: effect on various cellular functions, and dependency of cytolysis on various metabolic processes.
    Nissen-Meyer J; Kildahl-Andersen O; Austgulen R
    J Leukoc Biol; 1986 Aug; 40(2):121-32. PubMed ID: 3090178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a lipid-like cytotoxin from human CD16+ natural killer cells.
    Cosentino LM; Cathcart MK
    Cancer Res; 1989 Dec; 49(23):6662-9. PubMed ID: 2531033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of monocyte cytotoxic factor in cytolysis of actinomycin D-treated WEHI 164 cells mediated by freshly isolated human adherent mononuclear blood cells.
    Austgulen R; Espevik T; Hammerstrøm J; Nissen-Meyer J
    Cancer Res; 1986 Sep; 46(9):4566-70. PubMed ID: 3524816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WEHI 164 sarcoma cells rendered resistant to monocyte-released cytotoxin are also resistant to monocyte-induced cytolysis.
    Kildahl-Andersen O; Austgulen R; Nissen-Meyer J
    Cancer Immunol Immunother; 1986; 21(1):77-80. PubMed ID: 3632918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of tumour necrosis factor in monocyte-mediated rapid killing of actinomycin D-pretreated WEHI 164 sarcoma cells.
    Bersani L; Colotta F; Mantovani A
    Immunology; 1986 Oct; 59(2):323-5. PubMed ID: 3770807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy.
    Kawakami M; Kawakami K; Stepensky VA; Maki RA; Robin H; Muller W; Husain SR; Puri RK
    Clin Cancer Res; 2002 Nov; 8(11):3503-11. PubMed ID: 12429641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytolysis of actinomycin D-treated target cells by cell-free supernatants from human monocytes.
    McKinnon KP; Chen AR; Argov S; Lane BC; Koren HS
    Immunobiology; 1986 Mar; 171(1-2):27-44. PubMed ID: 3710517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Production and function of the monocyte cytotoxic factor (MCF)].
    Uchida A
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2098-104. PubMed ID: 2440386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.